TCF-1 controls ILC2 and NKp46+ RORγt+ innate lymphocyte differentiation and protection in intestinal inflammation

Journal of Immunology

Volumn 191, Issue 8, 2013, Pages 4383-4391

  Mielke, Lisa A ^a   Groom, Joanna R ^a   Rankin, Lucille C ^a   Seillet, Cyril ^a   Masson, Frederick ^a   Putoczki, Tracy ^a   Belz, Gabrielle T ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; INNATE LYMPHOID CELL 3; INTERLEUKIN 13; INTERLEUKIN 22; INTERLEUKIN 5; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NOTCH2 RECEPTOR; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR 7; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL PROTECTION; CITROBACTER RODENTIUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTERITIS; IMMUNE RESPONSE; INNATE IMMUNITY; INTESTINE INFECTION; LYMPHOCYTE DIFFERENTIATION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, LY; CELL DIFFERENTIATION; CITROBACTER RODENTIUM; ENTEROBACTERIACEAE INFECTIONS; GATA3 TRANSCRIPTION FACTOR; INFLAMMATION; INTERLEUKIN-13; INTERLEUKIN-5; INTERLEUKINS; INTESTINES; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; MUCOUS MEMBRANE; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; RECEPTOR, NOTCH2; T CELL TRANSCRIPTION FACTOR 1; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTES;

EID: 84885439404     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301228     Document Type: Article

References (51)

1. Rankin, L., J. Groom, L. A. Mielke, C. Seillet, and G. T. Belz. 2013. Diversity, function, and transcriptional regulation of gut innate lymphocytes. Front. Immunol. 4: 22.
2. Neill, D. R., S. H.Wong, A. Bellosi, R. J. Flynn,M. Daly, T. K. Langford, C. Bucks, C. M. Kane, P. G. Fallon, R. Pannell, et al. 2010. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464: 1367-1370.
3. Moro, K., T. Yamada, M. Tanabe, T. Takeuchi, T. Ikawa, H. Kawamoto, J. I. Furusawa, M. Ohtani, H. Fujii, and S. Koyasu. 2010. Innate production of T (H)2 cytokines by adipose tissue-Associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463: 540-544.
4. Spits, H., and J. P. Di Santo. 2011. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat. Immunol. 12: 21-27.
5. Bernink, J., J. Mjösberg, and H. Spits. 2013. Th1-And Th2-like subsets of innate lymphoid cells. Immunol. Rev. 252: 133-138.
6. Kee, B. L. 2009. E and ID proteins branch out. Nat. Rev. Immunol. 9: 175-184.
7. Rankin, L., and G. T. Belz. 2011. Diverse roles of inhibitor of differentiation 2 in adaptive immunity. Clin. Dev. Immunol. 2011: 281569.
8. Murre, C. 2009. Developmental trajectories in early hematopoiesis. Genes Dev. 23: 2366-2370.
9. Satoh-Takayama, N., S. Lesjean-Pottier, P. Vieira, S. Sawa, G. Eberl, C. A. Vosshenrich, and J. P. Di Santo. 2010. IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors. J. Exp. Med. 207: 273-280.
10. Vonarbourg, C., A. Mortha, V. L. Bui, P. P. Hernandez, E. A. Kiss, T. Hoyler, M. Flach, B. Bengsch, R. Thimme, C. Hölscher, et al. 2010. Regulated expression of nuclear receptor RORgt confers distinct functional fates to NK cell receptor-expressing RORgt(+) innate lymphocytes. Immunity 33: 736-751.
11. Hoyler, T., C. S. Klose, A. Souabni, A. Turqueti-Neves, D. Pfeifer, E. L. Rawlins, D. Voehringer, M. Busslinger, and A. Diefenbach. 2012. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 37: 634-648.
12. Mjösberg, J., J. Bernink, K. Golebski, J. J. Karrich, C. P. Peters, B. Blom, A. A. te Velde, W. J. Fokkens, C. M. van Drunen, and H. Spits. 2012. The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity 37: 649-659.
13. Wong, S. H., J. A. Walker, H. E. Jolin, L. F. Drynan, E. Hams, A. Camelo, J. L. Barlow, D. R. Neill, V. Panova, U. Koch, et al. 2012. Transcription factor RORa is critical for nuocyte development. Nat. Immunol. 13: 229-236.
14. Chang, Y. J., H. Y. Kim, L. A. Albacker, N. Baumgarth, A. N. McKenzie, D. E. Smith, R. H. Dekruyff, and D. T. Umetsu. 2011. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat. Immunol. 12: 631-638.
15. Roediger, B., R. Kyle, K. H. Yip, N. Sumaria, T. V. Guy, B. S. Kim, A. J. Mitchell, S. S. Tay, R. Jain, E. Forbes-Blom, et al. 2013. Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells. Nat. Immunol. 14: 564-573.
16. Eberl, G., S. Marmon, M.-J. Sunshine, P. D. Rennert, Y. Choi, and D. R. Littman. 2004. An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. 5: 64-73.
17. Luci, C., A. Reynders, I. I. Ivanov, C. Cognet, L. Chiche, L. Chasson, J. Hardwigsen, E. Anguiano, J. Banchereau, D. Chaussabel, et al. 2009. Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat. Immunol. 10: 75-82.
18. Sonnenberg, G. F., L. A. Monticelli, T. Alenghat, T. C. Fung, N. A. Hutnick, J. Kunisawa, N. Shibata, S. Grunberg, R. Sinha, A. M. Zahm, et al. 2012. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 336: 1321-1325.
19. Zheng, Y., P. A. Valdez, D. M. Danilenko, Y. Hu, S. M. Sa, Q. Gong, A. R. Abbas, Z. Modrusan, N. Ghilardi, F. J. de Sauvage, and W. Ouyang. 2008. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14: 282-289.
20. Zenewicz, L. A., G. D. Yancopoulos, D. M. Valenzuela, A. J. Murphy, S. Stevens, and R. A. Flavell. 2008. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29: 947-957.
21. Finke, D., H. Acha-Orbea, A. Mattis, M. Lipp, and J. Kraehenbuhl. 2002. CD4 +CD32 cells induce Peyer's patch development: role of alpha4beta1 integrin activation by CXCR5. Immunity 17: 363-373.
22. Cupedo, T., G. Kraal, and R. E. Mebius. 2002. The role of CD45+CD4+CD32 cells in lymphoid organ development. Immunol. Rev. 189: 41-50.
23. Yokota, Y., A. Mansouri, S. Mori, S. Sugawara, S. Adachi, S. Nishikawa, and P. Gruss. 1999. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397: 702-706.
24. Sonnenberg, G. F., L. A. Monticelli, M. M. Elloso, L. A. Fouser, and D. Artis. 2011. CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 34: 122-134.
25. Takatori, H., Y. Kanno, W. T. Watford, C. M. Tato, G. Weiss, I. I. Ivanov, D. R. Littman, and J. J. O'Shea. 2009. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J. Exp. Med. 206: 35-41.
26. Cupedo, T., N. K. Crellin, N. Papazian, E. J. Rombouts, K. Weijer, J. L. Grogan, W. E. Fibbe, J. J. Cornelissen, and H. Spits. 2009. Human fetal lymphoid tissueinducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat. Immunol. 10: 66-74.
27. Rankin, L. C., J. R. Groom, M. Chopin, M. J. Herold, J. A. Walker, L. A. Mielke, A. N. McKenzie, S. Carotta, S. L. Nutt, and G. T. Belz. 2013. The transcription factor T-bet is essential for the development of NKp46+ innate lymphocytes via the Notch pathway. Nat. Immunol. 14: 389-395.
28. Sciumé, G., K. Hirahara, H. Takahashi, A. Laurence, A. V. Villarino, K. L. Singleton, S. P. Spencer, C.Wilhelm, A. C. Poholek, G. Vahedi, et al. 2012. Distinct requirements for T-bet in gut innate lymphoid cells. J. Exp. Med. 209: 2331-2338.
29. Klose, C. S., E. A. Kiss, V. Schwierzeck, K. Ebert, T. Hoyler, Y. d'Hargues, N. Göppert, A. L. Croxford, A. Waisman, Y. Tanriver, and A. Diefenbach. 2013. A T-bet gradient controls the fate and function of CCR6-RORgt+ innate lymphoid cells. Nature 494: 261-265.
30. Lee, J. S., M. Cella, K. G. McDonald, C. Garlanda, G. D. Kennedy, M. Nukaya, A. Mantovani, R. Kopan, C. A. Bradfield, R. D. Newberry, and M. Colonna. 2012. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat. Immunol. 13: 144-151.
31. Possot, C., S. Schmutz, S. Chea, L. Boucontet, A. Louise, A. Cumano, and R. Golub. 2011. Notch signaling is necessary for adult, but not fetal, development of RORgt(+) innate lymphoid cells. Nat. Immunol. 12: 949-958.
32. Yang, Q., L. A. Monticelli, S. A. Saenz, A. W. Chi, G. F. Sonnenberg, J. Tang, M. E. De Obaldia, W. Bailis, J. L. Bryson, K. Toscano, et al. 2013. T cell factor 1 is required for group 2 innate lymphoid cell generation. Immunity 38: 694-704.
33. Germar, K., M. Dose, T. Konstantinou, J. Zhang, H. Wang, C. Lobry, K. L. Arnett, S. C. Blacklow, I. Aifantis, J. C. Aster, and F. Gounari. 2011. T-cell factor 1 is a gatekeeper for T-cell specification in response to Notch signaling. Proc. Natl. Acad. Sci. USA 108: 20060-20065.
34. Weber, B. N., A. W. Chi, A. Chavez, Y. Yashiro-Ohtani, Q. Yang, O. Shestova, and A. Bhandoola. 2011. A critical role for TCF-1 in T-lineage specification and differentiation. Nature 476: 63-68.
35. Jackson, J. T., Y. Hu, R. Liu, F. Masson, A. D'Amico, S. Carotta, A. Xin, M. J. Camilleri, A. M. Mount, A. Kallies, et al. 2011. Id2 expression delineates differential checkpoints in the genetic program of CD8a+ and CD103+ dendritic cell lineages. EMBO J. 30: 2690-2704.
36. Kallies, A., J. Hasbold, D. M. Tarlinton, W. Dietrich, L. M. Corcoran, P. D. Hodgkin, and S. L. Nutt. 2004. Plasma cell ontogeny defined by quantitative changes in blimp-1 expression. J. Exp. Med. 200: 967-977.
37. Finotto, S., M. F. Neurath, J. N. Glickman, S. Qin, H. A. Lehr, F. H. Green, K. Ackerman, K. Haley, P. R. Galle, S. J. Szabo, et al. 2002. Development of spontaneous airway changes consistent with human asthma in mice lacking Tbet. Science 295: 336-338.
38. Verbeek, S., D. Izon, F. Hofhuis, E. Robanus-Maandag, H. te Riele, M. van de Wetering, M. Oosterwegel, A. Wilson, H. R. MacDonald, and H. Clevers. 1995. An HMG-box-containing T-cell factor required for thymocyte differentiation. Nature 374: 70-74.
39. Boos, M. D., Y. Yokota, G. Eberl, and B. L. Kee. 2007. Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity. J. Exp. Med. 204: 1119-1130.
40. Held, W., B. Kunz, B. Lowin-Kropf, M. van de Wetering, and H. Clevers. 1999. Clonal acquisition of the Ly49A NK cell receptor is dependent on the transacting factor TCF-1. Immunity 11: 433-442.
41. Barlow, J. L., S. Peel, J. Fox, V. Panova, C. S. Hardman, A. Camelo, C. Bucks, X. Wu, C. M. Kane, D. R. Neill, et al. 2013. IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction. J. Allergy Clin. Immunol. pii: S0091-6749(13)00829-4.
42. Waterman, M. L. 2004. Lymphoid enhancer factor/T cell factor expression in colorectal cancer. Cancer Metastasis Rev. 23: 41-52.
43. Malhotra, N., K. Narayan, O. H. Cho, K. E. Sylvia, C. Yin, H. Melichar, M. Rashighi, V. Lefebvre, J. E. Harris, L. J. Berg, and J. Kang; Immunological Genome Project Consortium. 2013. A network of high-mobility group box transcription factors programs innate interleukin-17 production. Immunity 38: 681-693.
44. Yu, Q., A. Sharma, A. Ghosh, and J. M. Sen. 2011. T cell factor-1 negatively regulates expression of IL-17 family of cytokines and protects mice from experimental autoimmune encephalomyelitis. J. Immunol. 186: 3946-3952.
45. Ma, J., R. Wang, X. Fang, Y. Ding, and Z. Sun. 2011. Critical role of TCF-1 in repression of the IL-17 gene. PLoS ONE 6: e24768.
46. Rosenbauer, F., B. M. Owens, L. Yu, J. R. Tumang, U. Steidl, J. L. Kutok, L. K. Clayton, K. Wagner, M. Scheller, H. Iwasaki, et al. 2006. Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1. Nat. Genet. 38: 27-37.
47. Baba, Y., K. Maeda, T. Yashiro, E. Inage, F. Niyonsaba, M. Hara, R. Suzuki, Y. Ohtsuka, T. Shimizu, H. Ogawa, et al. 2012. Involvement of PU.1 in mast cell/ basophil-specific function of the human IL1RL1/ST2 promoter. Allergol. Int. 61: 461-467.
48. Walker, J. A., J. L. Barlow, and A. N. McKenzie. 2013. Innate lymphoid cells- how did we miss them? Nat. Rev. Immunol. 13: 75-87.
49. Intlekofer, A. M., N. Takemoto, E. J. Wherry, S. A. Longworth, J. T. Northrup, V. R. Palanivel, A. C. Mullen, C. R. Gasink, S. M. Kaech, J. D. Miller, et al. 2005. Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat. Immunol. 6: 1236-1244.
50. Pearce, E. L., A. C. Mullen, G. A. Martins, C. M. Krawczyk, A. S. Hutchins, V. P. Zediak, M. Banica, C. B. DiCioccio, D. A. Gross, C. A. Mao, et al. 2003. Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science 302: 1041-1043.
51. Endo, Y., C. Iwamura, M. Kuwahara, A. Suzuki, K. Sugaya, D. J. Tumes, K. Tokoyoda, H. Hosokawa, M. Yamashita, and T. Nakayama. 2011. Eomesodermin controls interleukin-5 production in memory T helper 2 cells through inhibition of activity of the transcription factor GATA3. Immunity 35: 733-745.